Medipee gets new investors

The Moers-based start-up makes it easy to analyze urine and the results are fed into an app. Now two companies are investing in Medipee.

Medipee was able to attract two investors in its Series A financing round. The Swiss sanitary products company Geberit and WBG Holding, which operates several care homes in Germany, are investing in Medipee.

The Moers-based start-up uses a small measuring device in the toilet to quickly analyze urine. The results can be viewed via an app to which the device transmits the information. The method replaces the small cups we are familiar with from visits to the doctor. WBG sees Medipee as a direct help for its care homes: "We see the benefits in the entire medical and nursing service area," says Managing Director Christoph Wagner.

"For us, the round is a significant milestone on the way to the market launch of our Medipee platform technology," says Co-Managing Director Frank Willems. He founded the start-up together with Thomas Prokopp and Paul Brandi in 2017. The aim of the financing round is to add a Medipee product to the directory of digital health applications. The start-up plans to submit a corresponding application in the second quarter of 2021. Once approved, the product can be prescribed by prescription.